GigaGen Gets More Than $1M in Grants to Develop Cell-Seq Technology | GenomeWeb

NEW YORK (GenomeWeb News) – Genetics-based diagnostic company GigaGen today said that it has received four grants totaling more than $1 million to develop and validate its Cell-Seq technology to aid in the prediction of immune flares in transplant recipients and autoimmune patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.